NexPoint Capital Updates Valuation

The Dallas-based investment firm recalibrates share valuation in line with board-approved policies.

December 20, 2024


NAV Revision Anchors NexPoint’s Distribution Plan


NexPoint Capital, Inc. has reported an updated net asset value (NAV) per share of $5.56 as of November 30, 2024. The revision will serve as the basis for the company’s Distribution Reinvestment Plan (DRP). NexPoint's valuation aligns with policies established by its investment adviser and approved by its board of directors under the Investment Company Act of 1940.


The updated NAV reflects the company’s commitment to transparency and equity for shareholders. Share issuance under the DRP will strictly follow the NAV calculations, with price adjustments not exceeding 2.5% above the determined NAV. This structure ensures consistency and fairness for participants in the reinvestment program.


Compliance and Future Outlook


NexPoint reiterated its adherence to federal regulations and its valuation policies in making these adjustments. The investment firm emphasized the importance of these updates in providing stability amidst dynamic market conditions.

Positioning for Long-Term Performance


The valuation adjustments showcase NexPoint’s active portfolio management strategy, balancing asset changes with prevailing market factors. As an investment company, NexPoint continuously evaluates its portfolio to maintain alignment with investor interests and broader economic conditions.


Despite uncertainties in the investment landscape, NexPoint remains optimistic about future opportunities. The firm has encouraged investors to stay informed about upcoming NAV disclosures and to consider the evolving market dynamics affecting its diversified asset base.


Further information about NexPoint Capital can be obtained by visiting their office at 300 Crescent Court, Suite 700, Dallas, Texas, or contacting them via phone at (972) 934-4700.

Share


Read More Articles

Newbridge Hit with $125K Fine for AML Violations

Steele Creek Capital Expands CLO Strategy

Adaptiiv Medical Technologies Raises Nearly $1M in Exempt Securities Offering


Sign Up For Our Newsletter To Get Daily News